AIM: To investigate the agreement and prognostic value of different measures of covert hepatic encephalopathy (CHE). METHODS: One-hundred-and-thirty-two cirrhotic outpatients underwent electroencephalography (EEG), paper-and-pencil psychometry (PHES) and critical flicker frequency, scored on the original/modified (CFFo/CFFm) thresholds. Eighty-four patients underwent Doppler-ultrasound to diagnose/exclude portal-systemic shunt. Seventy-nine were followed-up for 11 ± 7 mo in relation to the occurrence of hepatic encephalopathy (HE)-related hospitalisations. RESULTS: On the day of study, 36% had grade I HE, 42% abnormal EEG, 33% abnormal PHES and 31/21% abnormal CFFo/CFFm. Significant associations were observed between combinations of test abnormalities; however, agreement was poor (Cohen's κ < 0.4). The prevalence of EEG, PHES and CFFo/CFFm abnormalities was significantly higher in patients with grade I overt HE. The prevalence of EEG and CFFm abnormalities was higher in patients with shunt. The prevalence of EEG abnormalities was significantly higher in patients with a history of HE. During follow-up, 10 patients died, 10 were transplanted and 29 had HE-related hospitalisations. Grade I HE (P = 0.004), abnormal EEG (P = 0.008) and abnormal PHES (P = 0.04) at baseline all predicted the subsequent occurrence of HE; CFF did not. CONCLUSION: CHE diagnosis probably requires a combination of clinical, neurophysiological and neuropsychological indices.
AIM: To investigate the agreement and prognostic value of different measures of covert hepatic encephalopathy (CHE). METHODS: One-hundred-and-thirty-two cirrhotic outpatients underwent electroencephalography (EEG), paper-and-pencil psychometry (PHES) and critical flicker frequency, scored on the original/modified (CFFo/CFFm) thresholds. Eighty-four patients underwent Doppler-ultrasound to diagnose/exclude portal-systemic shunt. Seventy-nine were followed-up for 11 ± 7 mo in relation to the occurrence of hepatic encephalopathy (HE)-related hospitalisations. RESULTS: On the day of study, 36% had grade I HE, 42% abnormal EEG, 33% abnormal PHES and 31/21% abnormal CFFo/CFFm. Significant associations were observed between combinations of test abnormalities; however, agreement was poor (Cohen's κ < 0.4). The prevalence of EEG, PHES and CFFo/CFFm abnormalities was significantly higher in patients with grade I overt HE. The prevalence of EEG and CFFm abnormalities was higher in patients with shunt. The prevalence of EEG abnormalities was significantly higher in patients with a history of HE. During follow-up, 10 patients died, 10 were transplanted and 29 had HE-related hospitalisations. Grade I HE (P = 0.004), abnormal EEG (P = 0.008) and abnormal PHES (P = 0.04) at baseline all predicted the subsequent occurrence of HE; CFF did not. CONCLUSION: CHE diagnosis probably requires a combination of clinical, neurophysiological and neuropsychological indices.
Authors: P Amodio; P Marchetti; F Del Piccolo; M de Tourtchaninoff; P Varghese; C Zuliani; G Campo; A Gatta; J M Guérit Journal: Clin Neurophysiol Date: 1999-08 Impact factor: 3.708
Authors: Annemarie Goldbecker; Karin Weissenborn; Golschan Hamidi Shahrezaei; Kambiz Afshar; Stefan Rümke; Hannelore Barg-Hock; Christian P Strassburg; Hartmut Hecker; Anita Blanka Tryc Journal: Gut Date: 2013-01-07 Impact factor: 23.059
Authors: P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim Journal: Hepatology Date: 2001-02 Impact factor: 17.425
Authors: Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei Journal: Hepatology Date: 2002-03 Impact factor: 17.425
Authors: Manuel Romero-Gómez; Juan Córdoba; Rodrigo Jover; Juan A del Olmo; Marta Ramírez; Ramón Rey; Enrique de Madaria; Carmina Montoliu; David Nuñez; Montse Flavia; Luis Compañy; José M Rodrigo; Vicente Felipo Journal: Hepatology Date: 2007-04 Impact factor: 17.425
Authors: Jasmohan S Bajaj; Andrew Fagan; Melanie B White; James B Wade; Phillip B Hylemon; Douglas M Heuman; Michael Fuchs; Binu V John; Chathur Acharya; Masoumeh Sikaroodi; Patrick M Gillevet Journal: Am J Gastroenterol Date: 2019-07 Impact factor: 10.864
Authors: Sanath Allampati; Andres Duarte-Rojo; Leroy R Thacker; Kavish R Patidar; Melanie B White; Jagpal S Klair; Binu John; Douglas M Heuman; James B Wade; Christopher Flud; Robert O'Shea; Edith A Gavis; Ariel B Unser; Jasmohan S Bajaj Journal: Am J Gastroenterol Date: 2015-12-08 Impact factor: 10.864